Is Triamcinolone injection effective for treating a pimple?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Triamcinolone Injection for Acne Lesions

Intralesional triamcinolone acetonide is highly effective for treating individual inflammatory acne nodules and cysts, providing rapid improvement within 48-72 hours, but should only be used as adjuvant therapy for occasional stubborn lesions—not as a primary treatment strategy for patients with multiple lesions. 1, 2, 3

Indications and Efficacy

When to Use:

  • Large, painful inflammatory nodules or cysts that are at risk for scarring 1, 3
  • Particularly stubborn individual cystic lesions resistant to other therapies 1
  • Situations requiring rapid reduction in inflammation and pain 2, 3

Expected Results:

  • Most acne nodules flatten within 48-72 hours after injection 1, 2, 3
  • Provides rapid improvement in both inflammation and pain 2, 3

Proper Dosing and Technique

Concentration:

  • Use triamcinolone acetonide 10 mg/mL for nodular acne 1
  • May be diluted with sterile normal saline to 5 mg/mL or 3.3 mg/mL 1
  • Most dermatologists in clinical practice use 2.5 mg/mL (52.5% of surveyed practitioners) 4

Volume:

  • The most commonly used volume is 0.05 mL per lesion 4
  • Using lower concentrations and smaller volumes minimizes complications 1

Injection Technique:

  • Inject into the center of the lesion 4
  • The American Academy of Dermatology recommends using the minimum effective amount 2

Critical Limitations and Contraindications

When NOT to Use:

  • Not effective for patients with multiple lesions 1, 3
  • Should not be injected at sites of active infections (impetigo, herpes) 1
  • Avoid in patients with previous hypersensitivity to triamcinolone 1
  • Large injections should be avoided in those with active tuberculosis or systemic fungal infection 1

Adverse Effects and Risk Mitigation

Common Complications:

  • Local atrophy at injection sites (consistent side effect) 1, 2, 5
  • Hypopigmentation and pigmentary changes 1, 5
  • Telangiectasias 1
  • When atrophy occurs, it typically lasts over 6 months (48.4% of cases) 4

Less Common but Serious:

  • Hypertrichosis 1
  • Sterile abscess 1
  • Steroid acne 1
  • Repeated injections can suppress the hypothalamic-pituitary-adrenal axis 1
  • Anaphylaxis, angioedema, and urticaria (rare) 1

Risk Reduction Strategy:

  • Use the lowest effective concentration and volume 1, 2
  • Apply sparingly to skin folds and intertriginous areas 2
  • Counsel patients on potential adverse effects (hypopigmentation and atrophy) before every injection—50.5% of dermatologists do this routinely 4
  • Despite concerns, observed skin atrophy rates are extremely low in practice (less than 1% of patients return for adverse events in 88.8% of practices) 4

Role in Comprehensive Acne Management

Positioning in Treatment Algorithm:

  • Intralesional triamcinolone is an adjuvant therapy only, not a standalone treatment 1, 3
  • Should be reserved for occasional or particularly stubborn cystic lesions 1
  • Must be used alongside appropriate systemic and topical therapies 1

For Severe Nodular Acne:

  • Patients with severe nodular acne, significant psychosocial burden, or scarring should be considered candidates for isotretinoin as definitive therapy 1, 3
  • Isotretinoin achieves 90% lesion reduction in 81% of patients at 20 weeks 3
  • Intralesional corticosteroids can provide rapid relief while initiating systemic treatment 1, 3

Enhanced Efficacy Option

Combination Therapy:

  • Adding intralesional lincomycin (75 mg/mL) to triamcinolone (2.5 mg/mL) produces superior results compared to triamcinolone alone 6
  • At one week, 100% of patients treated with the combination showed 100% improvement versus 70% showing 66% improvement with triamcinolone alone 6
  • This improvement remained stable at one month 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Triamcinolone Acetonide Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Complications of Nodular Cystic Acne

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dermatologist Use of Intralesional Triamcinolone in the Treatment of Acne.

The Journal of clinical and aesthetic dermatology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.